Although there is some contradiction, the mutational signature 30, somatic loss of a second allele, or promoter methylation have typically not been observed in heterozygous NTHL1 variant carriers12,25,27,32,33—in these individuals, the possible increased risk of cancer has been suggested to be caused by haploinsufficiency25. Here, NTHL1 is linked to cancer.